45,205 Shares in Stoke Therapeutics, Inc. $STOK Acquired by Principal Financial Group Inc.

robot
Abstract generation in progress

Principal Financial Group Inc. recently acquired a new position of 45,205 shares in Stoke Therapeutics, Inc. (NASDAQ:STOK) during the third quarter, valued at approximately $1,062,000. Other institutional investors have also adjusted their holdings in STOK, with several increasing their stakes. The article also details recent analyst ratings which generally recommend a “Buy” or “Moderate Buy” for the stock, and reports on insider selling activity by a director and general counsel of Stoke Therapeutics.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin